Leukotrienes contribute significantly to inflammation, bronchoconstriction, and mucus production in the airways. Leukotriene modifiers, such as montelukast, zafirlukast, and zileuton, work by blocking the action of leukotrienes or inhibiting their synthesis, thereby reducing inflammation and relaxing the airways. This makes breathing easier and helps prevent asthma symptoms.
